{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:33:48Z","timestamp":1771666428414,"version":"3.50.1"},"reference-count":41,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:sec><jats:label\/><jats:p> <jats:italic>J. Neurochem.<\/jats:italic> (2010) <jats:bold>113<\/jats:bold>, 351\u2013362.<\/jats:p><\/jats:sec><jats:sec><jats:title>Abstract<\/jats:title><jats:p>Recent etiological studies have revealed that molecular mimicry between the lipo\u2010oligosaccharide (LOS) component of <jats:italic>Campylobacter jejuni<\/jats:italic> and gangliosides of peripheral nervous system plays an important role in the pathogenesis of Guillain\u2010Barr\u00e9 syndrome (GBS). Previously, we demonstrated GD3 ganglioside molecular mimicry in a model of GBS in Lewis rats by sensitization with GD3\u2010like LOS (LOS<jats:sub>GD3<\/jats:sub>) from <jats:italic>C. jejuni<\/jats:italic>. Since the neuropathophysiological consequences were due largely to the anti\u2010GD3\u2010like antibodies, we subsequently focused our effort upon eliminating the pathogenic antibodies using several strategies to mimic GD3 in this model. Here, we have validated this strategy by the use of peptide glycomimics based on epitopic mimicry between carbohydrates and peptides. We treated rats by i.p. administration of phage\u2010displayed GD3\u2010like peptides. One GD3\u2010like peptide (P<jats:sub>GD3<\/jats:sub>\u20104; RHAYRSMAEWGFLYS) induced in treated rats a remarkable restoration of motor nerve functions, as evidenced by improved histopathology, rotarod performance, and motor nerve conduction velocity. P<jats:sub>GD3<\/jats:sub>\u20104 effectively decreased the titer of anti\u2010GD3\/anti\u2010LOS<jats:sub>GD3<\/jats:sub> antibodies and ameliorated peripheral nerve dysfunction in the sera of treated rats. The data suggest that peptide glycomimics of ganglioside may be potential powerful reagents for therapeutic intervention in GBS by neutralizing specific pathogenic anti\u2010ganglioside antibodies.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1471-4159.2010.06627.x","type":"journal-article","created":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T16:19:17Z","timestamp":1265041157000},"page":"351-362","source":"Crossref","is-referenced-by-count":10,"title":["Development of a novel therapy for Lipo\u2010oligosaccharide\u2010induced experimental neuritis: use of peptide glycomimics"],"prefix":"10.1111","volume":"113","author":[{"given":"Seigo","family":"Usuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoji","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi\u2010Hua","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,3,16]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.20395"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/jb.174.4.1324-1332.1992"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00167a032"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410440610"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115276"},{"key":"e_1_2_7_7_1","volume-title":"The PyMOL Molecular Graphics System","author":"DeLano W. L.","year":"2002"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.3030460322"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6837"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.1150181505"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)12308-X"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67665-9"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1086\/513793"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(99)00195-2"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1968.tb09743.x"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2006.09.013"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwp027"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000160399.08456.7C"},{"key":"e_1_2_7_19_1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/WCO.0b013e3282ef79e3","article-title":"Monoclonal gammopathy and neuropathy","volume":"20","author":"Lozeron P.","year":"2007","journal-title":"Curr. Opin. Neurol."},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00124499"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2006.01.063"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2007.10.008"},{"key":"e_1_2_7_23_1","doi-asserted-by":"crossref","first-page":"12632","DOI":"10.1016\/S0021-9258(18)42324-1","article-title":"O\u2010Acetylated gangliosides in bovine buttermilk. Characterization of 7\u2010O\u2010acetyl, 9\u2010O\u2010acetyl, and 7,9\u2010di\u2010O\u2010acetyl GD3","volume":"267","author":"Ren S.","year":"1992","journal-title":"J. Biol. Chem."},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.28.10.2060"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.64.8.2945-2949.1996"},{"key":"e_1_2_7_26_1","first-page":"57","article-title":"Python: a programming language for software integration and development","volume":"17","author":"Sanner M. F.","year":"1999","journal-title":"J. Mol. Graph. Model"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0104-17"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2002.01247.x"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)40231-7"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2004.07.011"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2005.01.007"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.20717"},{"key":"e_1_2_7_33_1","article-title":"Novel anti\u2010idiotype antibody therapy for lipooligosaccharide\u2010induced experimental autoimmune neuritis: use relevant to Guillain\u2010Barr\u00e9 Syndrome","author":"Usuki S.","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-9781(99)00095-9"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4547(19960401)44:1<58::AID-JNR8>3.0.CO;2-H"},{"key":"e_1_2_7_36_1","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4049\/jimmunol.157.4.1582","article-title":"Characterization of an Ig VH idiotope that results in specific homophilic binding and increased avidity for antigen","volume":"157","author":"Yan X.","year":"1996","journal-title":"J. Immunol."},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R300020-JLR200"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00967-06"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20762"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.12.1900"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.5.1771"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0402391101"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.2010.06627.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.2010.06627.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T18:43:09Z","timestamp":1698950589000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.2010.06627.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,16]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1111\/j.1471-4159.2010.06627.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06627.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,16]]}}}